Hyman Charles D Abbott Laboratories Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Abbott Laboratories stock. As of the latest transaction made, Hyman Charles D holds 44,635 shares of ABT stock, worth $5.03 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

44,635

Previous 44,605 0.07%

Holding current value

$5.03 Million

Previous $5.07 Million 8.5%

% of portfolio

0.26%

Previous 0.28%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $3,021 - $3,373	30 Added 0.07%	44,635 $4.64 Million
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $29,132 - $32,175	266 Added 0.6%	44,605 $5.07 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $22,276 - $27,268	247 Added 0.56%	44,339 $4.88 Million
Q3 2023 Nov 01, 2023	BUY	$95.53 - $114.62 $12,609 - $15,129	132 Added 0.3%	44,092 $4.27 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $120,203 - $141,486	1,241 Added 2.91%	43,960 $4.45 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $1,354 - $1,568	14 Added 0.03%	42,719 $4.13 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $7,655 - $9,252	75 Added 0.18%	42,705 $4.64 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $30,101 - $36,706	-264 Reduced 0.62%	42,630 $5.05 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $466,290 - $515,852	-3,997 Reduced 8.52%	42,894 $5.07 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $47,775 - $52,061	-455 Reduced 0.96%	46,891 $5.13 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $61,857 - $75,120	-675 Reduced 1.41%	47,346 $5.15 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $2,373 - $3,038	31 Added 0.06%	48,021 $4.39 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $67,971 - $99,392	-1,082 Reduced 2.2%	47,990 $3.79 Million
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $58,882 - $65,550	750 Added 1.55%	49,072 $4.26 Million
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $7,871 - $9,180	108 Added 0.22%	48,322 $4.06 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $592,073 - $715,816	8,941 Added 22.77%	48,214 $3.85 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1,945 - $2,347	32 Added 0.08%	39,273 $2.88 Million
Q2 2017 Aug 14, 2017	BUY	N/A	39,241	39,241 $1.91 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account